Correlation of REL copy number and REL nuclear accumulation with clinical features
. | . | REL copy no. . | . | % REL-positive nuclei . | . | ||
|---|---|---|---|---|---|---|---|
| Patient characteristics . | All patients . | Less than 4* . | 4 or more† . | 50% or less‡ . | 70% or more§ . | ||
| Male/female, no. | 29/17 | 21/13 | 5/4 | 15/7 | 10/7 | ||
| Median age, y (range) | 62 (25-84) | 63 (29-84) | 63 (41-75) | 63 (29-79) | 67 (25-80) | ||
| Stage | |||||||
| I, no. (%) | 12 (26) | 10 (29) | 2 (22) | 4 (18) | 6 (35) | ||
| II, no. (%) | 14 (30.5) | 8 (24) | 5 (56) | 7 (32) | 5 (29) | ||
| III, no. (%) | 6 (13) | 4 (12) | 0 (0) | 3 (14) | 3 (18) | ||
| IV, no. (%) | 14 (30.5) | 12 (35) | 2 (22) | 8 (36) | 3 (18) | ||
| Pure EN disease, no. (%) | 10 (22) | 7 (21) | 3 (33) | 4 (18) | 4 (24) | ||
| IPI risk group∥ | |||||||
| Low, no. (%) | 13 (29) | 10 (30.5) | 1 (11) | 7 (32) | 6 (35) | ||
| Low-intermediate, no. (%) | 13 (29) | 8 (24) | 5 (56) | 6 (27) | 4 (23.5) | ||
| High-intermediate, no. (%) | 7 (15.5) | 6 (18) | 1 (11) | 3 (14) | 3 (18) | ||
| High, no. (%) | 12 (26.5) | 9 (27.5) | 2 (22) | 6 (27) | 4 (23.5) | ||
. | . | REL copy no. . | . | % REL-positive nuclei . | . | ||
|---|---|---|---|---|---|---|---|
| Patient characteristics . | All patients . | Less than 4* . | 4 or more† . | 50% or less‡ . | 70% or more§ . | ||
| Male/female, no. | 29/17 | 21/13 | 5/4 | 15/7 | 10/7 | ||
| Median age, y (range) | 62 (25-84) | 63 (29-84) | 63 (41-75) | 63 (29-79) | 67 (25-80) | ||
| Stage | |||||||
| I, no. (%) | 12 (26) | 10 (29) | 2 (22) | 4 (18) | 6 (35) | ||
| II, no. (%) | 14 (30.5) | 8 (24) | 5 (56) | 7 (32) | 5 (29) | ||
| III, no. (%) | 6 (13) | 4 (12) | 0 (0) | 3 (14) | 3 (18) | ||
| IV, no. (%) | 14 (30.5) | 12 (35) | 2 (22) | 8 (36) | 3 (18) | ||
| Pure EN disease, no. (%) | 10 (22) | 7 (21) | 3 (33) | 4 (18) | 4 (24) | ||
| IPI risk group∥ | |||||||
| Low, no. (%) | 13 (29) | 10 (30.5) | 1 (11) | 7 (32) | 6 (35) | ||
| Low-intermediate, no. (%) | 13 (29) | 8 (24) | 5 (56) | 6 (27) | 4 (23.5) | ||
| High-intermediate, no. (%) | 7 (15.5) | 6 (18) | 1 (11) | 3 (14) | 3 (18) | ||
| High, no. (%) | 12 (26.5) | 9 (27.5) | 2 (22) | 6 (27) | 4 (23.5) | ||